Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA Remuneration Information 2021

Jun 3, 2021

3633_rns_2021-06-03_b8caaf7f-e4d0-4bca-8525-c6564e5fcf35.html

Remuneration Information

Open in viewer

Opens in your device viewer

Grant of Incentive Subscription Rights in IDEX Biometrics 3 June 2021

Grant of Incentive Subscription Rights in IDEX Biometrics 3 June 2021

The board of directors of IDEX Biometrics ASA resolved on 3 June 2021 to issue

2,000,000 incentive subscription rights to an officer in the IDEX group. The

grant was made under the company's 2021 incentive subscription rights plan as

resolved at the annual general meeting on 12 May 2021. The exercise price of the

subscription rights is NOK 2.38 per share. The subscription rights vest by 25%

per year over four years and expire on 12 May 2026. Following the grant there

are 62,053,609 subscription rights outstanding in IDEX.

Primary insider

Catharina Eklof, Chief Commercial Officer of IDEX Biometrics ASA, received on 3

June 2021 a grant of 2,000,000 incentive subscription rights to shares in IDEX.

The grant was made for no consideration. IDEX shares have ISIN NO0003070609.

For further information contact:

Marianne Bøe, Investor Relations

E-mail: [email protected]

Tel: + 47 9180 0186

Brett L. Perry, U.S. Investor Relations

E-mail: [email protected]

Tel: +1 214 272 0070

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of

fingerprint identification technologies offering simple, secure, and personal

touch-free authentication for all.  We help people make payments, prove their

identity, gain access to information, unlock devices, or gain admittance to

buildings with the touch of a finger. We invent, engineer, and commercialize

these secure, yet incredibly user-friendly solutions.  Our total addressable

market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter

@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section

5-12 the Norwegian Securities Trading Act